Cancer-associated thrombosis (CAT) is a condition in which relevance has been
increasingly recognised both for physicians that deal with venous thromboembolism (VTE) …

2.1. 1. Epidemiology and burden of the disease. The annual incidence of first episode of
symptomatic DVT in the adult population ranges from 50 to 100 per 100 000 population, with …

Abstract Purpose of Review This review aims to summarize the epidemiology, current
pathophysiologic understanding, and state-of-the-art treatment of venous thromboembolism …

Venous thromboembolism (VTE) can be the first manifestation of cancer. Although four
prospective studies have suggested that limited occult cancer screening might be adequate …

Venous thromboembolism (VTE) is a common complication for cancer patients. VTE-
associated risk varies according to the type of tumor disease. Head and neck cancer is a …

Background Venous thromboembolism is common in patients with malignancies, affecting
up to 10% of this patient population. The association between arterial ischemic events and …

Background Venous thromboembolism (VTE) can be the first manifestation of cancer;
however, the current incidence of malignancy in unselected patients with first unprovoked …

Respiratory diseases exhibit diverse patterns in prevalence, clinical presentations, and
outcomes between men and women. Historically, certain conditions were more prevalent in …

Abstract Background The Registro Informatizado de Pacientes con Enfermedad
TromboEmbólica (RIETE) score and the Screening for Occult Malignancy in Patients with …

Essentials Patients at high‐risk of occult cancer may benefit from extensive screening. We
validated the RIETE cancer score in the MVTEP study. One in three patients were classified …